Skip to NavigationSkip to content

News

AstraZeneca’s Brilinta (ticagrelor) reduced the composite of stroke and death in patients with head and neck artery atherosclerosis who had an acute...
Pfizer has filed a petition in a US court against Indian companies Dr Reddy’s Laboratories and Aurobindo Pharma that alleges the pair were planning...
J&J is set to receive an additional $454 million from BARDA to fund its ongoing Phase 3 studies of its adenovirus-based vaccine candidate in a...
Pfizer is set to launch its first delivery programme for the COVID-19 vaccine it developed with BioNTech. It will be located in multiple sites across...
95 cases of COVID-19 were confirmed in the patient population. Of these total cases, 90 were identified in the placebo group, whereas only five were...
"All the immunisation vaccination approaches must be accomplished before next autumn. And I’m confident that this will happen because there are a...
ENSEMBLE 2 is aiming to recruit patients from the UK, the US, France, Germany, South Africa, Spain, Belgium, Colombia and the Philippines, countries...
The British Labour Party has called for the implementation of new legal measures to combat anti-vaccination campaigns on the internet and social...
The antidepressant fluvoxamine could treat COVID-19 patients and stop their symptoms from worsening, according to a new study.
The British Prime Minister Boris Johnson has begun working in self isolation after coming into contact with an MP who later tested positive for...
Mission Statement
Pharmafile.com is a leading portal for the pharmaceutical industry, providing industry professionals with pharma news, pharma events, pharma service company listings and pharma jobs,
Site content is produced by our editorial team exclusively for Pharmafile.com and our industry newspaper Pharmafocus. Service company profiles and listings are taken from our pharmaceutical industry directory, Pharmafile, and presented in a unique Find and Compare format to ensure the most relevant matches